SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-02-000134
Filing Date
2002-01-11
Accepted
2002-01-11 00:00:00
Documents
4
Period of Report
2002-01-11
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b41620aie8-k.txt 8-K 3840
3 UNDERWRITING AGREEMENT b41620aiex1-2.txt EX-1.2 119390
4 OPINION OF PALMER & DODGE b41620aiex5-2.txt EX-5.2 2359
5 RISK FACTORS b41620aiex99-1.txt EX-99.1 31864
  Complete submission text file 0000950135-02-000134.txt   159375
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 2507440
SIC: 2836 Biological Products, (No Diagnostic Substances)